Arkolith/Insider Trading/COLL/Form 4

Kuhlmann Shirley R.

EVP and General CounselCOLLEGIUM PHARMACEUTICAL, INC (COLL) · full profile →Form 4 · filed Mar 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.4M
Net Open-Market Flow
-$2.4M
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 6, 2025Sell(S)26K$28.50$743K108K
Mar 5, 2025Sell(S)20K$28.03$561K134K
Mar 4, 2025Sell(S)40K$28.08$1.1M154K
Mar 4, 2025Option exercise(M)40K$24.03$961K194K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2025Option exercise(M)40K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-004776) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML